Amneal Pharmaceuticals Inc - ESG Rating & Company Profile powered by AI
The assessment of Amneal Pharmaceuticals Inc employs data from across the internet and also from public documents by Amneal Pharmaceuticals Inc. This Disclosure score includes seventeen UN Sustainable Development Goals including: 'Quality Education', 'Sustainable Cities & Communities' and 'Life on Land'. If you are employed by Amneal Pharmaceuticals Inc and you would like to use your ESG rating, please contact us.
Amneal Pharmaceuticals Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 8.0; made up of an environmental score of 8.0, social score of 8.0 and governance score of 8.0.
8.0
High ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Amneal Pharmaceuticals Inc | 8.0 | High |
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Amneal Pharmaceuticals Inc have an accelerator or VC vehicle to help deliver innovation?
Does Amneal Pharmaceuticals Inc disclose current and historical energy intensity?
Does Amneal Pharmaceuticals Inc report the average age of the workforce?
Does Amneal Pharmaceuticals Inc reference operational or capital allocation in relation to climate change?
Does Amneal Pharmaceuticals Inc disclose its ethnicity pay gap?
Does Amneal Pharmaceuticals Inc disclose cybersecurity risks?
Does Amneal Pharmaceuticals Inc offer flexible work?
Does Amneal Pharmaceuticals Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Amneal Pharmaceuticals Inc disclose the number of employees in R&D functions?
Does Amneal Pharmaceuticals Inc conduct supply chain audits?
Does Amneal Pharmaceuticals Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Amneal Pharmaceuticals Inc conduct 360 degree staff reviews?
Does Amneal Pharmaceuticals Inc disclose the individual responsible for D&I?
Does Amneal Pharmaceuticals Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Amneal Pharmaceuticals Inc disclose current and / or historical scope 2 emissions?
Does Amneal Pharmaceuticals Inc disclose water use targets?
Does Amneal Pharmaceuticals Inc have careers partnerships with academic institutions?
Did Amneal Pharmaceuticals Inc have a product recall in the last two years?
Does Amneal Pharmaceuticals Inc disclose incidents of discrimination?
Does Amneal Pharmaceuticals Inc allow for Work Councils/Collective Agreements to be formed?
Has Amneal Pharmaceuticals Inc issued a profit warning in the past 24 months?
Does Amneal Pharmaceuticals Inc disclose parental leave metrics?
Does Amneal Pharmaceuticals Inc disclose climate scenario or pathway analysis?
Does Amneal Pharmaceuticals Inc disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Amneal Pharmaceuticals Inc disclose the pay ratio of women to men?
Does Amneal Pharmaceuticals Inc support suppliers with sustainability related research and development?
Does Amneal Pharmaceuticals Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Amneal Pharmaceuticals Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Amneal Pharmaceuticals Inc involved in embryonic stem cell research?
Does Amneal Pharmaceuticals Inc disclose GHG and Air Emissions intensity?
Does Amneal Pharmaceuticals Inc disclose its waste policy?
Does Amneal Pharmaceuticals Inc report according to TCFD requirements?
Does Amneal Pharmaceuticals Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Amneal Pharmaceuticals Inc disclose energy use targets?
Does Amneal Pharmaceuticals Inc disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Amneal Pharmaceuticals Inc have a policy relating to cyber security?
Have a different question?
Potential Risks for Amneal Pharmaceuticals Inc
These potential risks are based on the size, segment and geographies of the company.
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates in three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals across a range of therapeutic categories. The Specialty segment is involved in the development, promotion, distribution, and sale of branded pharmaceutical products primarily for central nervous system disorders, endocrinology, parasitic infections, and other therapeutic areas. It also offers licensed, owned, niche, and mature branded products, as well as Rytary for the treatment of Parkinson's disease; Zomig for the treatment of migraine headaches; Emverm a chewable tablets for the treatment of pinworm, whipworm, common roundworm, common hookworm, and American hookworm in single or mixed infections; and Unithroid for the treatment of hypothyroidism. The AvKARE segment provides pharmaceuticals, medical and surgical products, and services primarily to governmental agencies, the Department of Defense, and the Department of Veterans Affairs. It is also involved in the wholesale distribution of bottle and unit dose pharmaceuticals under the AvKARE and AvPAK names, as well as medical and surgical products; and packaging and wholesale distribution of pharmaceuticals and vitamins to its retail and institutional customers. The company sells its products through wholesalers, distributors, hospitals, chain pharmacies, and individual pharmacies. It operates in the United States, India, Ireland, and internationally. The company was formerly known as Atlas Holdings, Inc. and changed its name to Amneal Pharmaceuticals, Inc. in 2018. Amneal Pharmaceuticals, Inc. was founded in 2002 and is based in Bridgewater, New Jersey.